MIM
WGSWW

Monashee Investment Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

Monashee Investment Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-133,332
Closed -$283K – 119
2021
Q3 		$283K Hold
133,332
– – 0.05% 142
2021
Q2 		$613K Hold
133,332
– – 0.07% 231
2021
Q1 		$691K Hold
133,332
– – 0.11% 208
2020
Q4 		$364K Buy
+133,332
New +$335K 0.05% 196

Other funds holding WGSWW

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return

Monashee Investment Management's WGSWW Position: Q4 2021 in Review

Monashee Investment Management sold out of GeneDx Holdings Warrant (WGSWW) in Q4 2021, closing a stake of 133,332 shares — an estimated $283K sold.

Monashee Investment Management first reported a position in WGSWW in Q4 2020 and held it in 4 quarters. The position peaked at $691K in Q1 2021. 33 funds tracked by Wall St. Rank hold WGSWW as of Q4 2021.

  • Monashee Investment Management reported no remaining GeneDx Holdings Warrant position as of Q4 2021 after selling out during the quarter.
  • Monashee Investment Management sold 133,332 GeneDx Holdings Warrant shares in Q4 2021, an estimated $283K.
  • Monashee Investment Management first reported a position in GeneDx Holdings Warrant in Q4 2020 and held it in 4 quarters.
  • Monashee Investment Management's GeneDx Holdings Warrant position peaked at $691K in Q1 2021.
  • 33 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q4 2021.

Based on Monashee Investment Management's 13F filing for Q4 2021, filed 7 Feb 2022.